M. Seeber

Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients

K. Jamerson, B. Dahlöf, R. Guthrie, 2011, Current medical research and opinion.

Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up

H. Figulla, B. Fujita, M. Ferrari, 2012, Basic Research in Cardiology.

Original Research: Telmisartan plus Amlodipine in Patients with Moderate or Severe Hypertension: Results from a Subgroup Analysis of a Randomized, Placebo-Controlled, Parallel-Group, 4 × 4 Factorial Study

R. Guthrie, C. Majul, T. Littlejohn, 2009, Postgraduate medicine.

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Raymond L. Forbes, A. Astrup, F. Greenway, 2017, The Lancet.

The Effects of Telmisartan and Amlodipine in Treatment-Naïve and Previously Treated Hypertensive Patients: A Subanalysis from a 4 × 4 Factorial Design Study

B. Dahlöf, H. Schumacher, C. Majul, 2013, Clinical and experimental hypertension.

Results of Treatment With Telmisartan‐Amlodipine in Hypertensive Patients

R. Guthrie, C. Majul, W. Oigman, 2009, Journal of clinical hypertension.

Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1–2 hypertension

G. Mancia, W. White, H. Schumacher, 2010, Blood pressure monitoring.